Estonian Statistics on Medicines 2017 1/42

Estonian Statistics on Medicines 2017 1/42

Estonian Statistics on Medicines 2017 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 169,5987 A01 STOMATOLOGICAL PREPARATIONS 0,0723 A01A STOMATOLOGICAL PREPARATIONS 0,0723 A01AA Caries prophylactic agents A01AA01 Sodium fluoride (dental) 51 g A01AB Antiinfectives and antiseptics for local oral treatment 0,0723 A01AB09 Miconazole (O) 6958,4 g 0,2 g 0,0723 A01AB12 Hexetidine (O) 1802400 ml A01AB81 Neomycin+ Benzocaine (dental) 30900 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 460 g A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 210860 g A01AD81 Lidocaine+ Cetrimide (O) 34685 g A01AD82 Choline salicylate (O) 780560 pieces A01AD83 Lidocaine+ Chamomille extract (O) 371950 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 528 g A02 DRUGS FOR ACID RELATED DISORDERS 48,6099 A02A ANTACIDS 1,0401 Combinations and complexes of aluminium, calcium and A02AD 1,0401 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 768200 pieces 10 pieces 0,1597 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3461134 ml 50 ml 0,1439 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3543408 pieces 10 pieces 0,7366 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 47,5697 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,1028 A02BA02 Ranitidine (O) 300308,25 g 0,3 g 2,0808 A02BA02 Ranitidine (P) 3175,75 g 0,3 g 0,022 A02BC Proton pump inhibitors 45,4595 A02BC01 Omeprazole (O) 257962,34 g 0,02 g 26,8113 A02BC02 Pantoprazole (O) 196205,1 g 0,04 g 10,1963 A02BC02 Pantoprazole (P) 461,2 g 0,04 g 0,024 A02BC03 Lansoprazole (O) 10,5 g 0,03 g 0,0007 A02BC05 Esomeprazole (O) 118787,76 g 0,03 g 8,2308 A02BC05 Esomeprazole (P) 2834,8 g 0,03 g 0,1964 A02BD Combinations for eradication of Helicobacter pylori <0,0001 A02BD08 Bismuth subcitrate+ Tetracycline+ Metronidazole (O) 120 pieces 12 pieces <0,0001 Other drugs for peptic ulcer and gastro-oesophageal reflux A02BX 0,0073 disease (GORD) A02BX02 Sucralfate (O) 13850 g 4 g 0,0072 A02BX05 Bismuth subcitrate (O) 33,6 g 0,48 g 0,0001 A02BX80 Vonoprazan (O) 3 g DRUGS FOR FUNCTIONAL GASTROINTESTINAL A03 7,9427 DISORDERS DRUGS FOR FUNCTIONAL GASTROINTESTINAL A03A 7,0126 DISORDERS A03AA Synthetic anticholinergics, esters with tertiary amino group 0,9891 A03AA04 Mebeverine (O) 142746 g 0,3 g 0,9891 A03AB Synthetic anticholinergics, quaternary ammonium compounds <0,0001 A03AB02 Glycopyrronium (P) 0,006 g 3 mg <0,0001 A03AD Papaverine and derivatives 4,4561 A03AD01 Papaverine hydrochloride (P) 66,2 g 0,1 g 0,0014 A03AD02 Drotaverine (O) 210001,28 g 0,1 g 4,3653 A03AD02 Drotaverine (P) 4303 g 0,1 g 0,0894 A03AX Other drugs for functional gastrointestinal disorders 1,5674 A03AX13 Simeticone (O) 377005,5437 g 0,5 g 1,5674 A03B BELLADONNA AND DERIVATIVES, PLAIN 0,0905 1/42 Estonian Statistics on Medicines 2017 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A03BA Belladonna alkaloids, tertiary amines 0,0782 A03BA01 Atropine (O, P) 17,34 g 0,0015 g 0,024 A03BA01 Atropine (P) 39,08 g 0,0015 g 0,0542 Belladonna alkaloids, semisynthetic, quaternary ammonium A03BB 0,0123 compounds A03BB01 Hyoscine butylbromide (O) 51,8 g 0,06 g 0,0018 A03BB01 Hyoscine butylbromide (P) 297,9 g 0,06 g 0,0103 A03BB01 Hyoscine butylbromide (R) 6,24 g 0,06 g 0,0002 A03F PROPULSIVES 0,8396 A03FA Propulsives 0,8396 A03FA01 Metoclopramide (O) 9698 g 0,03 g 0,672 A03FA01 Metoclopramide (P) 1874,9 g 0,03 g 0,1299 A03FA03 Domperidone (O) 544,14 g 0,03 g 0,0377 A04 ANTIEMETICS AND ANTINAUSEANTS 0,1243 A04A ANTIEMETICS AND ANTINAUSEANTS 0,1243 A04AA Serotonin (5-HT3) antagonists 0,1107 A04AA01 Ondansetron (P) 34,76 g 0,016 g 0,0045 A04AA02 Granisetron (O) 59,76 g 0,002 g 0,0621 A04AA02 Granisetron (P) 63,61 g 0,003 g 0,0441 A04AD Other antiemetics 0,0136 A04AD01 Scopolamine (TD) 10 pieces 1 pieces <0,0001 A04AD12 Aprepitant (O) 332,025 g 0,095 g 0,0073 A04AD81 Fosaprepitant (P) 288,45 g 0,095 g 0,0063 A05 BILE AND LIVER THERAPY 2,2636 A05A BILE THERAPY 0,4938 A05AA Bile acid preparations 0,4938 A05AA02 Ursodeoxycholic acid (O) 178150 g 0,75 g 0,4938 A05B LIVER THERAPY, LIPOTROPICS 1,7698 A05BA Liver therapy 1,7698 A05BA03 Silymarin (O) 2644490 pieces A05BA80 Essential phospholipids (O) 2554230 pieces 3 pieces 1,7698 A05BA80 Essential phospholipids (P) 1945 pieces A06 DRUGS FOR CONSTIPATION 15,5975 A06A DRUGS FOR CONSTIPATION 15,5975 A06AB Contact laxatives 7,4335 A06AB02 Bisacodyl (O) 14969,2 g 0,01 g 3,1116 A06AB02 Bisacodyl (R) 999 g 0,01 g 0,2077 A06AB06 Senna glycosides (O) 8440 pieces 1 pieces 0,0175 A06AB08 Sodium picosulfate (O) 9852,8073 g 0,005 g 4,0962 A06AB80 Sodium picosulfate+ Magnesium oxide+ Citric acid (O) 460 pieces 2 pieces 0,0005 A06AC Bulk-forming laxatives <0,0001 A06AC01 Hemicellulose of Ispaghula (O) 0,585 g 7 g <0,0001 A06AD Osmotically acting laxatives 7,3069 A06AD11 Lactulose (O) 22314644,9 g 6,7 g 6,9232 A06AD15 Macrogol (O) 1846000 g 10 g 0,3837 Macrogol+ Sodium citrate+ Citric acid+ Sodium chloride+ A06AD80 14400 ml Potassium chloride (O) Sodium sulphate, anhydrous+ Potassium chloride+ Sodium A06AD81 58596 pieces chloride+ Macrogol+ Sodium hydrogen carbonate (O) Macrogol+ Sodium sulphate, anhydrous+ Sodium chloride+ A06AD83 280 pieces Potassium chloride+ Ascorbic acid+ Sodium ascorbate (O) Sodium sulphate, anhydrous+ magnesium sulfate A06AD85 796224 ml heptahydrate+ Potassium sulphate (O) A06AG Enemas 0,8499 A06AG11 Laurilsulfate, incl. combinations+ Sorbitol+ Sodium citrate (R) 408872 pieces 1 pieces 0,8499 A06AH Peripheral opioid receptor antagonists 0,0071 2/42 Estonian Statistics on Medicines 2017 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A06AH03 Naloxegol (O) 85,5 g 25 mg 0,0071 ANTIDIARRHEALS, INTESTINAL A07 4,0713 ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS A07A INTESTINAL ANTIINFECTIVES 0,0003 A07AA Antibiotics 0,0003 A07AA02 Nystatin (O) 20000000 U 1500000 U <0,0001 A07AA06 Paromomycin (O) 42 g A07AA11 Rifaximin (O) 55,2 g 0,6 g 0,0002 A07AA12 Fidaxomicin (O) 8 g 0,4 g <0,0001 A07B INTESTINAL ADSORBENTS 0,4412 A07BC Other intestinal adsorbents 0,4412 A07BC05 Diosmectidum (O) 1910070 g 9 g 0,4412 A07C ELECTROLYTES WITH CARBOHYDRATES A07CA Oral rehydration salt formulations Sodium chloride+ Potassium chloride+ Sodium citrate+ A07CA80 68200 pieces Glucose (O) A07D ANTIPROPULSIVES 0,9968 A07DA Antipropulsives 0,9968 A07DA03 Loperamide (O) 4795,472 g 0,01 g 0,9968 A07DA06 Eluxadoline (O) 16,8 g A07E INTESTINAL ANTIINFLAMMATORY AGENTS 2,0161 A07EA Corticosteroids acting locally 0,0023 A07EA06 Budesonide (O) 9,99 g 0,009 g 0,0023 A07EA06 Budesonide (R) 0,9352 g A07EC Aminosalicylic acid and similar agents 2,0137 A07EC01 Sulfasalazine (O) 796650 g 2 g 0,828 A07EC02 Mesalazine (O) 788185 g 1,5 g 1,0923 A07EC02 Mesalazine (R) 67458 g 1,5 g 0,0935 A07F ANTIDIARRHEAL MICROORGANISMS 0,617 A07FA Antidiarrheal microorganisms 0,617 A07FA02 Saccharomyces boulardii (O) 296797,5 g 1 g 0,617 A07X OTHER ANTIDIARRHEALS A07XA Other antidiarrheals A07XA04 Racecadotril (O) 3311 g A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS 0,0522 A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS 0,0522 A08AA Centrally acting antiobesity products 0,0363 A08AA62 Bupropione+ Naltrexone (O) 69776 pieces 4 pieces 0,0363 A08AB Peripherally acting antiobesity products 0,016 A08AB01 Orlistat (O) 2766,96 g 0,36 g 0,016 A09 DIGESTIVES, INCL. ENZYMES 1,4828 A09A DIGESTIVES, INCL. ENZYMES 1,4828 A09AA Enzyme preparations 1,4827 A09AA02 Lipase+ Amylase+ Protease (O) 2853211 pieces 4 pieces 1,4827 A09AC Enzyme and acid preparations, combinations 0,0001 A09AC80 Pepsin+ Betaine (O) 150 pieces 3 pieces 0,0001 A10 DRUGS USED IN DIABETES 62,3756 A10A INSULINS AND ANALOGUES 16,3017 A10AB Insulins and analogues for injection, fast-acting 6,1563 A10AB01 Insulin (human) (P) 874500 U 40 U 0,0454 A10AB04 Insulin lispro (P) 25911000 U 40 U 1,3465 A10AB05 Insulin aspart (P) 77940000 U 40 U 4,0503 A10AB06 Insulin glulisine (P) 13738500 U 40 U 0,714 A10AC Insulins and analogues for injection, intermediate-acting 0,1188 A10AC01 Insulin (human) (P) 2286000 U 40 U 0,1188 Insulins and analogues for injection, intermediate- or long- A10AD 1,2917 acting combined with fast-acting 3/42 Estonian Statistics on Medicines 2017 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A10AD04 Insulin lispro (P) 8655000 U 40 U 0,4498 A10AD05 Insulin aspart (P) 16201500 U 40 U 0,842 A10AE Insulins and analogues for injection, long-acting 8,7349 A10AE04 Insulin glargine (P) 102192750 U 40 U 5,3107 A10AE05 Insulin detemir (P) 65892000 U 40 U 3,4242 A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS 46,0739 A10BA Biguanides 20,0821 A10BA02 Metformin (O) 19321782 g 2 g 20,0821 A10BB Sulfonylureas 14,4784 A10BB07 Glipizide (O) 1154,55 g 0,01 g 0,24 A10BB09 Gliclazide (O) 232998,6 g 0,06 g 8,0722 A10BB12 Glimepiride (O) 5932,68 g 0,002 g 6,1661 A10BD Combinations of oral blood glucose lowering drugs 5,0782 A10BD07 Metformin+ Sitagliptin (O) 2025856 pieces 2 pieces 2,1056 A10BD08 Metformin+ Vildagliptin (O) 949140 pieces 2 pieces 0,9865 A10BD10 Metformin+ Saxagliptin (O) 321240 pieces 2 pieces 0,3339 A10BD11 Metformin+ Linagliptin (O) 769740 pieces 2 pieces 0,8 A10BD15 Metformin+ Dapagliflozin (O) 255024 pieces 2 pieces 0,2651 A10BD19 Linagliptin+ Empagliflozin (O) 17910 pieces 1 pieces 0,0372 A10BD20 Metformin+ Empagliflozin (O) 495780 pieces 2 pieces 0,5153 A10BD21 Saxagliptin+ Dapagliflozin (O)

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    42 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us